Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
1939.
NOTES, COMMENTS AND ABSTRACTS.
The Lancet,
Vol. 234,
Issue. 6064,
p.
1105.
Blair, Donald
1940.
The Modern Treatment of Epilepsy.
Journal of Mental Science,
Vol. 86,
Issue. 364,
p.
888.
Coope, Robert
and
Burrows, RobertG.R.
1940.
TREATMENT OF EPILEPSY WITH SODIUM DIPHENYL HYDANTOINATE.
The Lancet,
Vol. 235,
Issue. 6081,
p.
490.
Chaiken, Bernard H.
Goldberg, Bernard I.
and
Segal, Jack P.
1950.
Dilantin Sensitivity.
New England Journal of Medicine,
Vol. 242,
Issue. 23,
p.
897.
Gaillard, R. A.
1957.
Antihistaminic Therapy for Gingival Hyperplasia Due to Dilantin.
New England Journal of Medicine,
Vol. 256,
Issue. 2,
p.
76.
HUNTER, RICHARD A.
1959.
Status Epilepticus History, Incidence and Problems.
Epilepsia,
Vol. 1,
Issue. 1-5,
p.
162.
Angelopoulos, A.P.
and
Goaz, P.W.
1972.
Incidence of diphenylhydantoin gingival hyperplasia.
Oral Surgery, Oral Medicine, Oral Pathology,
Vol. 34,
Issue. 6,
p.
898.
Hassell, T. M.
and
Page, R. C.
1978.
The major metabolite of phenytoin (Dilantin) induces gingival overgrowth in cats.
Journal of Periodontal Research,
Vol. 13,
Issue. 3,
p.
280.
Keppel Hesselink, Jan M.
2017.
Phenytoin: a step by step insight into its multiple mechanisms of action—80 years of mechanistic studies in neuropharmacology.
Journal of Neurology,
Vol. 264,
Issue. 9,
p.
2043.
eLetters
No eLetters have been published for this article.